Adicon Holdings (09860) soared more than 70% in the morning session, with the morning gain falling to 26%. As of the time of publication, it rose 26.56%, closing at 8.1 Hong Kong dollars, with a turnover of 96.1351 million Hong Kong dollars.
According to the Futu Securities app, Adicon Holdings (09860) soared more than 70% in the morning session, with the morning gain falling to 26%. As of the time of publication, it rose 26.56%, closing at 8.1 Hong Kong dollars, with a turnover of 96.1351 million Hong Kong dollars.
On the news front, on the afternoon of November 23, the National Medical Insurance Bureau held a press conference to interpret the issued guidelines for 17 batches of medical service price projects. In order to support the entry of relatively mature AI-assisted technologies into clinical applications, while preventing additional patient burden, the National Medical Insurance Bureau analyzed the potential application scenarios of AI. Setting up the 'AI-assisted' expansion items in radiological examinations, ultrasound examinations, and rehabilitation projects allows hospitals to choose to train medical staff for diagnosis and treatment, or to use AI in the process without charging additional fees at the current stage.
Jiang Bingzhen, from the National Healthcare Security Administration's Pharmaceutical Pricing and Tendering Procurement Department, stated that in order to prevent additional patient burden, the National Medical Insurance Bureau analyzed the potential application scenarios of artificial intelligence. They established 'artificial intelligence-assisted' expanded items in radiological examinations, ultrasound examinations, and rehabilitation projects. Under the same price level, hospitals can choose to train medical personnel to provide corresponding medical services to patients, or to involve artificial intelligence in the diagnosis and treatment process.
It is reported that Adicon Holdings mainly provides testing services for hospitals, medical institutions, physical examination centers, consumers, pharmaceutical companies, and Contract Research Organizations (CROs). The company's testing services mainly include general examinations, special examinations, clinical immunology testing, clinical chemistry testing, clinical molecular biology testing, pathological testing, and other testing.